Omarigliptin serves as the focus of this category, which includes high-quality pharmaceutical reference standards essential for the analytical assessment of this compound. As a potent dipeptidyl peptidase-4… Read more











Omarigliptin serves as the focus of this category, which includes high-quality pharmaceutical reference standards essential for the analytical assessment of this compound. As a potent dipeptidyl peptidase-4 (DPP-4) inhibitor, Omarigliptin is used in the treatment of type 2 diabetes mellitus. Pharmaceutical laboratories require these specialized materials, including impurity reference standards, metabolites, and stable isotope labelled compounds, for critical analytical workflows such as impurity profiling, method validation, and routine quality control. By providing a reliable benchmark for analytical measurements, these products enable researchers to accurately identify and quantify process-related impurities and degradation products. These materials are instrumental in supporting rigorous scientific analysis and maintaining strict quality standards throughout the drug development and manufacturing lifecycle, helping to ensure data integrity and compliance with international guidelines for pharmaceutical purity and potency.